martes, 21 de julio de 2020

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK | BMC Cancer | Full Text

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK | BMC Cancer | Full Text

Patients with metastatic renal cell carcinoma (mRCC) treated with targeted systemic therapies have demonstrated favourable outcomes in randomised controlled trials, however real-world evidence is limited. Thus...
Authors:Robert Hawkins, Kate Fife, Michael Hurst, Meng Wang, Niroshini Naicker, Sarah Nolasco, Tim Eisen, Athena Matakidou and Jason Gordon
Citation:BMC Cancer 2020 20:670
Content type:Research article
 
Published on: 

No hay comentarios:

Publicar un comentario